Skip to main content
Log in

SOX2/SALL4 stemness axis modulates Notch signaling genes to maintain self-renewal capacity of esophageal squamous cell carcinoma

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Stemness phenotype is considered as the centerpiece of cancer biology due to its potential in conventional chemo-radiotherapy resistance and tumor recurrence after clinical intervention. This feature in tumor mass belongs to activation of core regulatory stemness factors and different cell signaling pathways in cancer stem cells. We aimed in this study to elucidate contribution of Notch signaling pathway in stemness state of esophageal squamous cell carcinoma (ESCC) through their relevance with stem cell markers SOX2 and SALL4. 50 ESCC tumor and related margin normal tissues were considered and categorized based on SOX2/SALL4 expression pattern, and mRNA levels of Notch signaling genes including ligands, receptors, target genes, and transcriptional coactivator were analyzed in the selected groups using qRT-PCR. Concomitant overexpression of stem cell markers SOX2 and SALL4 in ESCCs upregulated the involved genes in Notch signaling pathway. Upregulation of Notch pathway genes associated with depth of tumor invasion and lymph node metastasis of ESCC. Based on biological function of SOX2 and SALL4 axis in stemness state potential, our results may suggest contribution of Notch signaling pathway in self-renewal capacity of ESCCs, as well as invasion and metastasis of the disease. To the best of our knowledge, this is the first report elucidating the crosstalk between SOX2/SALL4 stemness factors and Notch signaling pathway in cancer research.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Data availability

All raw data are available on case of reasonable request from corresponding author.

Abbreviations

CSCs:

Cancer stem cells

EMT:

Epithelial mesenchymal transition

ESCs:

Embryonic stem cells

ESCC:

Esophageal squamous cell carcinoma

iPS:

Induced pluripotent stem

TF:

Transcription factor

References

  1. Tanimura N, Saito M, Ebisuya M, Nishida E, Ishikawa F (2013) Stemness-related factor Sall4 interacts with transcription factors Oct-3/4 and Sox2 and occupies Oct-Sox elements in mouse embryonic stem cells. J Biol Chem 288(7):5027–5038

    Article  CAS  PubMed  Google Scholar 

  2. Prokopi M, Kousparou CA, Epenetos AA (2014) The secret role of microRNAs in cancer stem cell development and potential therapy: a notch-pathway approach. Front Oncol 4:389. https://doi.org/10.3389/fonc.2014.00389

    Article  PubMed  Google Scholar 

  3. Zhao W, Li Y, Zhang X (2017) Stemness-related markers in cancer. Cancer Transl Med 3(3):87–95

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Hassan KA, Wang L, Korkaya H, Chen G, Maillard I, Beer DG, Kalemkerian GP, Wicha MS (2013) Notch pathway activity identifies cells with cancer stem cell-like properties and correlates with worse survival in lung adenocarcinoma. Clin Cancer Res 19(8):1972–1980

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Qi H, Pei D (2007) The magic of four: induction of pluripotent stem cells from somatic cells by Oct4, Sox2, Myc and Klf4. Cell Res 17(7):578–580

    Article  CAS  PubMed  Google Scholar 

  6. Zhang J, Tam WL, Tong GQ, Wu Q, Chan HY, Soh BS, Lou Y, Yang J, Ma Y, Chai L, Ng HH, Lufkin T, Robson P, Lim B (2006) Sall4 modulates embryonic stem cell pluripotency and early embryonic development by the transcriptional regulation of Pou5f1. Nat Cell Biol 8(10):1114–1123

    Article  CAS  PubMed  Google Scholar 

  7. Yang J, Gao C, Chai L, Ma Y (2010) A novel SALL4/OCT4 transcriptional feedback network for pluripotency of embryonic stem cells. PLoS ONE 5(5):e10766

    Article  PubMed  PubMed Central  Google Scholar 

  8. Forghanifard MM, Ardalan Khales S, Javdani-Mallak A, Rad A, Farshchian M, Abbaszadegan MR (2014) Stemness state regulators SALL4 and SOX2 are involved in progression and invasiveness of esophageal squamous cell carcinoma. Med Oncol 31(4):922. https://doi.org/10.1007/s12032-014-0922-7

    Article  CAS  PubMed  Google Scholar 

  9. Hashemi Bidokhti M, Abbaszadegan MR, Sharifi N, Abbasi Sani S, Forghanifard MM (2017) Contribution of MAML1 in esophageal squamous cell carcinoma tumorigenesis. Ann Diagn Pathol 27:79–82

    Article  PubMed  Google Scholar 

  10. Forghanifard MM, Taleb S, Abbaszadegan MR (2015) Notch signaling target genes are directly correlated to esophageal squamous cell carcinoma tumorigenesis. Pathol Oncol Res 21(2):463–467

    Article  CAS  PubMed  Google Scholar 

  11. Natsuizaka M, Whelan KA, Kagawa S, Tanaka K, Giroux V, Chandramouleeswaran PM, Long A, Sahu V, Darling DS, Que J, Yang Y, Katz JP, Wileyto EP, Basu D, Kita Y, Natsugoe S, Naganuma S, Klein-Szanto AJ, Diehl JA, Bass AJ, Wong KK, Rustgi AK, Nakagawa H (2017) Interplay between Notch1 and Notch3 promotes EMT and tumor initiation in squamous cell carcinoma. Nat Commun 8(1):1758. https://doi.org/10.1038/s41467-017-01500-9

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Triana-Martinez F, Loza MI, Dominguez E (2020) Beyond tumor suppression: senescence in cancer stemness and tumor dormancy. Cells 9(2):346. https://doi.org/10.3390/cells9020346

    Article  CAS  PubMed Central  Google Scholar 

  13. Sugahara S, Fujimoto T, Kondoh H, Uchikawa M (2018) Nasal and otic placode specific regulation of Sox2 involves both activation by Sox-Sall4 synergism and multiple repression mechanisms. Dev Biol 433(1):61–74

    Article  CAS  PubMed  Google Scholar 

  14. Cochrane CR, Szczepny A, Watkins DN, Cain JE (2015) Hedgehog signaling in the maintenance of cancer stem cells. Cancers 7(3):1554–1585

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Valkenburg KC, Graveel CR, Zylstra-Diegel CR, Zhong Z, Williams BO (2011) Wnt/beta-catenin signaling in normal and cancer stem cells. Cancers 3(2):2050–2079

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Thompson MD, Monga SP (2007) WNT/beta-catenin signaling in liver health and disease. Hepatology 45(5):1298–1305

    Article  CAS  PubMed  Google Scholar 

  17. Wang Y, Krivtsov AV, Sinha AU, North TE, Goessling W, Feng Z, Zon LI, Armstrong SA (2010) The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML. Science 327(5973):1650–1653

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Stine RR, Matunis EL (2013) JAK-STAT signaling in stem cells. Adv Exp Med Biol 786:247–267

    Article  CAS  PubMed  Google Scholar 

  19. Morgensztern D, McLeod HL (2005) PI3K/Akt/mTOR pathway as a target for cancer therapy. Anticancer Drugs 16(8):797–803

    Article  CAS  PubMed  Google Scholar 

  20. Abel EV, Kim EJ, Wu J, Hynes M, Bednar F, Proctor E, Wang L, Dziubinski ML, Simeone DM (2014) The notch pathway is important in maintaining the cancer stem cell population in pancreatic cancer. PLoS ONE 9(3):e91983

    Article  PubMed  PubMed Central  Google Scholar 

  21. Capaccione KM, Pine SR (2013) The notch signaling pathway as a mediator of tumor survival. Carcinogenesis 34(7):1420–1430

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Zhu W, Niu J, He M, Zhang L, Lv X, Liu F, Jiang L, Zhang J, Yu Z, Zhao L, Bi J, Yan Y, Wei Q, Huo H, Fan Y, Chen Y, Ding J, Wei M (2019) MOESM3 of SNORD89 promotes stemness phenotype of ovarian cancer cells by regulating Notch1-c-Myc pathway. J Transl Med 17(1):259. https://doi.org/10.1186/s12967-019-2005-1

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Korkaya H, Wicha MS (2009) HER-2, notch, and breast cancer stem cells: targeting an axis of evil. Clin Cancer Res 15(6):1845–1847

    Article  CAS  PubMed  Google Scholar 

  24. Wang J, Wakeman TP, Lathia JD, Hjelmeland AB, Wang XF, White RR, Rich JN, Sullenger BA (2010) Notch promotes radioresistance of glioma stem cells. Stem Cells 28(1):17–28

    CAS  PubMed  PubMed Central  Google Scholar 

  25. Seo EJ, Kim DK, Jang IH, Choi EJ, Shin SH, Lee SI, Kwon SM, Kim KH, Suh DS, Kim JH (2016) Hypoxia-NOTCH1-SOX2 signaling is important for maintaining cancer stem cells in ovarian cancer. Oncotarget 7(34):55624–55638

    Article  PubMed  PubMed Central  Google Scholar 

  26. Moghbeli M, Mosannen Mozaffari H, Memar B, Forghanifard MM, Gholamin M, Abbaszadegan MR (2019) Role of MAML1 in targeted therapy against the esophageal cancer stem cells. J Transl Med 17(1):126. https://doi.org/10.1186/s12967-019-1876-5

    Article  PubMed  PubMed Central  Google Scholar 

  27. Forghanifard MM, Moaven O, Farshchian M, Montazer M, Raeisossadati R, Abdollahi A, Moghbeli M, Nejadsattari T, Parivar K, Abbaszadegan MR (2012) Expression analysis elucidates the roles of MAML1 and Twist1 in esophageal squamous cell carcinoma aggressiveness and metastasis. Ann Surg Oncol 19(3):743–749

    Article  PubMed  Google Scholar 

  28. Taleb S, Abbaszadegan MR, Moghbeli M, Roudbari NH, Forghanifard MM (2014) HES1 as an independent prognostic marker in esophageal squamous cell carcinoma. J Gastrointest Cancer 45(4):466–471

    Article  CAS  PubMed  Google Scholar 

  29. Rad A, Esmaeili Dizghandi S, Abbaszadegan MR, Taghechian N, Najafi M, Forghanifard MM (2016) SOX1 is correlated to stemness state regulator SALL4 through progression and invasiveness of esophageal squamous cell carcinoma. Gene 594(2):171–175

    Article  CAS  PubMed  Google Scholar 

  30. Rad A, Farshchian M, Forghanifard MM, Matin MM, Bahrami AR, Geerts D, A’Rabi A, Memar B, Abbaszadegan MR (2016) Predicting the molecular role of MEIS1 in esophageal squamous cell carcinoma. Tumour Biol 37(2):1715–1725

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors gratefully acknowledge the colleagues at the Division of Human Genetics, Avicenna Research Institute, MUMS, for preparing ESCC tissue specimens.

Funding

Not applicable.

Author information

Authors and Affiliations

Authors

Contributions

MMF designed the study, performed the experiments, analyzed data, drafted and edited the manuscript. PK performed the experiments. MMF and MRA had a critical scientific revision on the manuscript.

Corresponding author

Correspondence to Mohammad Mahdi Forghanifard.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval and consent to participate

The study was approved by ethics committee of Mashhad University of Medical Sciences and informed consent was obtained from all individual participants included in the study.

Informed consent

Written informed consent was obtained from the patient for publication of their individual details and accompanying images in this manuscript.

Consent for publication

All authors declared their consent for publication.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Forghanifard, M.M., Kasebi, P. & Abbaszadegan, M.R. SOX2/SALL4 stemness axis modulates Notch signaling genes to maintain self-renewal capacity of esophageal squamous cell carcinoma. Mol Cell Biochem 476, 921–929 (2021). https://doi.org/10.1007/s11010-020-03956-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-020-03956-8

Keywords

Navigation